HCV-HIV viral load tests (reagent/instrument rental)

Ended Awarded Last action

Contract number
VA26117F0894
Awardee
Awarding agency
Obligated
$1,627,862

Award facts

Opportunity
Contract value 71% obligated
$2,283,975.75 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Rosemont, IL 60018, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 -$51,721
Funding Only Action P00011 -$265,429
Exercise an Option P00010 $100,981
Funding Only Action P00009 -$393,454
Exercise an Option P00008 · Exercising option year 4 $656,114
Funding Only Action P00006 · Deobligate unused FY19 funds -$457,906
Funding Only Action P00005 · Deob OY1 FY18 funds -$341,444
Funding Only Action P00004 · Deob FY17 funds -$243,736
Exercise an Option P00003 · Exercise OY3 $656,114
Exercise an Option P00002 · Exercise OY2 $656,114
Exercise an Option P00001 $656,114
Original award $656,114
Show all 12

About this award

This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the U.S. Department of Veterans Affairs (VA) for HCV-HIV viral load tests, including reagents and instrument rental. The contract has a total ceiling value of $2,283,975.75 and is a delivery order under the General Services Administration (GSA) Schedule 65-VII for In-vitro Diagnostics, Reagents, and Test. The contract does not have a set-aside designation. This award supports the VA's healthcare programs by providing critical viral load testing capabilities, including for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV). Abbott Molecular has extensive experience supplying diagnostic products and services to federal agencies, including the VA, Centers for Disease Control and Prevention, and Department of the Army. The parent company, Abbott Laboratories, is a global healthcare leader that has secured various Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency to deliver a wide range of medical equipment, diagnostics, and nutritional products.

Quick answers

Who was awarded contract VA26117F0894?

VA26117F0894 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on January 23, 2017.

How much is contract VA26117F0894 worth?

The government has obligated $1,627,862 on VA26117F0894. Its current value, with exercised options, is $2,283,976.

Is contract VA26117F0894 an order under another contract?

Yes. VA26117F0894 is a delivery order under V797D40222, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract VA26117F0894 competed?

The extent of competition for VA26117F0894 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award